Mindray Medical International (MR) Reports In-Line Q1 EPS of 34c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts MR Hot Sheet
Join SI Premium – FREE
Mindray Medical International (NYSE: MR) reported Q1 EPS of $0.34, in-line with the analyst estimate of $0.34. Revenue for the quarter came in at $219 million versus the consensus estimate of $217.49 million.
Mindray Medical International reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Mindray Medical International (MR) click here.
Mindray Medical International reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Mindray Medical International (MR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Truist names top clean energy stocks to watch ahead of Q3 earnings season
- JPMorgan Upgrades Dr. Reddy\'s Laboratories (DRRD:IN) (RDY) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
